Most healthcare deal teams are reactive.
They build a buy-box. They tell the bankers what they are looking for. They wait for the CIM to hit their inbox. And by the time they see the deal, so has everyone else in the market.
The result is predictable: you end up in a banker-run auction alongside four other bidders, working off the same CIM, racing through the same compressed diligence timeline, and overpaying for assets that half the market was already underwriting.
Bain and Sutton Place Strategies found that the average PE firm only sees 18% of the intermediated deals relevant to their strategy. For every 10 deals that should be crossing your desk, you are seeing fewer than 2.
And this is in a market that just hit $191 billion in healthcare PE deal value last year across 445 buyouts. That is not a rounding error. That is a structural gap in how most teams approach sourcing.
The firms that consistently get to sellers first are not waiting for processes. They are building pipelines before a banker ever gets hired. Here is how that works in practice.
On Thursday, I am breaking down the other side of this equation: the real cost of building this capability in-house. FTE cost, ramp time, SG&A drag, EBITDA impact at exit, and what it does to deal velocity when your team is building infrastructure instead of closing. If you are weighing hire vs. outsource, that one is for you.
Start With a Buy-Box That Actually Filters
"We like [specialty] in the Southeast" is not a buy-box. It is a preference.
A buy-box that drives real sourcing has hard parameters:
Specialty and sub-specialty: Every healthcare vertical has sub-segments with different reimbursement dynamics, referral patterns, and competitive landscapes. "We like urgent care" is not the same as "we want multi-site urgent care groups with 5+ locations, commercial-heavy payer mix, in MSAs where we already have health system partnerships."
Geography: State-level is too wide. Define it by MSA, by county, or by proximity to your existing footprint. A group 30 minutes from your flagship location is a different strategic conversation than one 4 hours away.
Size thresholds: Provider count, location count, estimated revenue range. A 2-provider single-site practice is a tuck-in. A 15-provider, multi-location group is a platform anchor. Your approach strategy is completely different for each.
Ownership type: Founder-owned with no succession plan? Group-owned with a management company? Already PE-backed and looking for a secondary? Each of these requires a different sourcing lens and a different pitch.
Payer mix signals: Heavy Medicare? Commercial-dominant? Medicaid exposure? This shapes your underwriting thesis before you ever see a financial statement.
The sharper the buy-box, the smaller and more actionable the target universe becomes. You are not trying to boil the ocean. You are trying to get from 200 names to the 10-15 that actually warrant a conversation.
Build the Target Universe Before Anyone Else Is Looking
Most teams start sourcing when they decide they want to enter a market. The best teams have already built the map.
The raw inputs are more accessible than most people think: